Literature DB >> 16570807

[Effect of Gleditsia sinensis stings on growth inhibition and expression of PCNA and p53 in mice bearing uterine cervical carcinoma (U14)].

Ling Long1, Guo-Xia Geng, Qing-Wang Li.   

Abstract

OBJECTIVE: To study the antitumor effect of the stings of Gleditsia sinensis on mice bearing uterine cervical carcinoma (U14) and the expression of PCNA (proliferating cell nuclear antigen) and p53.
METHOD: The effect of the ethanolic extract of G. sinensis stings on the inhibition rate of solid tumor and the life span of ascites tumor were calculated by the animal tumor model experiment in vivo. The positive cell numbers of PCNA and mutant p53 protein were measured by immunohistochemical SP method. RESULT: As compared with the control group, the ethanolic extract of G. sinensis stings (250, 500 and 1 000 mg x kg(-1) body weight, p.o.) and CTX (25 mg kg(-1) body weight, i.p.) administration significantly reduced the tumor weight of solid tumor and increased the life span of ascites tumor harboring mice (P < 0.01). The inhibition rate of solid tumor and the rate in life span were up to 47.44%, 59.49%, 63.92%, 73.42% and 52.21%, 67.26%, 78.76%, 95.58% respectively. Meanwhile,the expression of PCNA and mutant p53 protein also suppressed by ethanolic extract (P < 0.05, P < 0.01).
CONCLUSION: The stings of G. sinensis showed antitumor activity and its possible mechanism might be related with the expression inhibition of PCNA and mutant p53 protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16570807

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  2 in total

1.  Differential gene expression between skin and cervix induced by the E7 oncoprotein in a transgenic mouse model.

Authors:  E Ibarra Sierra; J Díaz Chávez; E M Cortés-Malagón; L Uribe-Figueroa; A Hidalgo-Miranda; P F Lambert; P Gariglio
Journal:  Virology       Date:  2012-09-11       Impact factor: 3.616

2.  Ethanol extract of Gleditsia sinensis thorn suppresses angiogenesis in vitro and in vivo.

Authors:  Jin-Mu Yi; Jong-Shik Park; Se-Mi Oh; Jun Lee; Jinhee Kim; Dal-Seok Oh; Ok-Sun Bang; No Soo Kim
Journal:  BMC Complement Altern Med       Date:  2012-12-04       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.